Evaluation of interleukin-8 -251 t/a polymorphisms in visceral leishmaniasis

Interleukin (IL)-8 plays important roles in the recruitment and activation of immune cells during visceral leishmaniasis (VL). Genetic variations in IL-8 modulate the expression of IL-8 protein and may be associated with VL. This study aimed to evaluate polymorphisms at the IL-8 -251 position in VL...

Full description

Saved in:
Bibliographic Details
Published inJournal of research in health sciences Vol. 15; no. 1; pp. 59 - 61
Main Authors Hajilooi, Mehrdad, Abasi, Mohammad, Bazmani, Ahad, Ahmadi, Alireza, Matini, Mohammad, Solgi, Ghasem, Sardarian, Khosro
Format Journal Article
LanguageEnglish
Published Iran 2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Interleukin (IL)-8 plays important roles in the recruitment and activation of immune cells during visceral leishmaniasis (VL). Genetic variations in IL-8 modulate the expression of IL-8 protein and may be associated with VL. This study aimed to evaluate polymorphisms at the IL-8 -251 position in VL patients. This cross-sectional study was performed on three groups: Leishmania-seropositive patients with clinical symptoms of VL (n = 91), seropositive patients without clinical symptoms (n = 104), and healthy controls (n = 110). Polymorphisms at the IL-8-251 position were analyzed using allele-specific polymerase chain reaction (PCR). Anti-Leishmania antibody titers were assessed by immunofluorescence. IL-8-251 polymorphism was significantly associated with VL (P<0.002). The IL-8-251 T/T genotype was significantly higher in group 1 than in groups 2 and 3 (P<0.002). The validity of the data was analyzed using Hardy-Weinberg equilibrium and one-way analysis of variance (ANOVA), as well as χ2 tests. IL-8-251 polymorphism was significantly associated with impaired immune responses in VL and might be considered a risk factor for disease development.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2228-7809